OpenAI has acquired Orchestra Bio, a platform that helps biopharmaceutical teams coordinate drug development. The team and technology will be combined with…
OpenAI has acquired Orchestra Bio, a platform that helps biopharmaceutical teams coordinate drug development. The team and technology will be combined with OpenAI's AI models and tools.
In the US, the path from identifying a therapeutic target to drug approval takes 10-15 years on average. The company hopes AI will help shorten this time.
Microsoft wants to lay off 27% of employees as AI rolls out35Today we're sending another 100 new invitations to the IT Community beta!26
🛂 Password manager 1Password launched a tool that lets AI agents sign in to accounts without access to passwords.20
🍏 Apple officially unveiled the first-ever MacBook Pro with a touch OLED screen and Dynamic Island. The iconic illuminated Apple logo is also making a…18
🔻 The wave of layoffs in major companies, long predicted due to AI, is now a reality — over the past few days, four giants announced mass cutbacks all at once:13
Microsoft introduced "medical superintelligence": the AI system diagnoses two to four times more accurately than doctors.18👀 Anthropic says it has an internal model that outperforms Mythos 5.1 in both capabilities and alignment. This follows from a re-analysis of a cybersecurity…17
🥬 Kitchen mini-farm promises fresh greens in 8 days: a British startup has unveiled two smart devices for growing greens at home.14
🎧 A small research lab Block showed Dessa, the most realistic voice AI model yet, which learned to speak from sound alone.10